RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Pancreatic lipase inhibitory activity of taraxacum officinale in vitro and in vivo

      한글로보기

      https://www.riss.kr/link?id=A82576165

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Obesity has become a worldwide health problem. Orlistat, an inhibitor of pancreatic lipase, is currently approved as an anti-obesity drug. However, gastrointestinal side effects caused by Orlistat may limit its use. In this study the inhibitory activities of dandelion (Taraxacum officinale) against pancreatic lipase in vitro and in vivo were measured to determine its possible use as a natural anti-obesity agent. The inhibitory activities of the 95% ethanol extract of T. officinale and Orlistat were measured using 4-methylumbelliferyl oleate (4-MU oleate) as a substrate at concentrations of 250, 125, 100, 25, 12.5 and 4 ㎍/㎖. To determine pancreatic lipase inhibitory activity in vivo, mice (n=16) were orally administered with corn oil emulsion (5 ㎖/㎏) alone or with the 95% ethanol extract of T. officinale (400 ㎎/㎏) following an overnight fast. Plasma triglyceride levels were measured at 0, 90, 180, and 240 min after treatment and incremental areas under the response curves (AUC) were calculated. The 95% ethanol extract of T. officinale and Orlistat, inhibited, porcine pancreatic lipase activity by 86.3% and 95.7% at a concentration of 250 ㎍/㎖, respectively. T. officinale extract showed dose-dependent inhibition with the IC50 of 78.2 μg/ml. A single oral dose of the extract significantly inhibited increases in plasma triglyceride levels at 90 and 180 min and reduced AUC of plasma triglyceride response curve (p<0.05). The results indicate that T. officinale exhibits inhibitory activities against pancreatic lipase in vitro and in vivo. Further studies to elucidate anti-obesity effects of chronic consumption of T. officinale and to identify the active components responsible for inhibitory activity against pancreatic lipase are necessary.
      번역하기

      Obesity has become a worldwide health problem. Orlistat, an inhibitor of pancreatic lipase, is currently approved as an anti-obesity drug. However, gastrointestinal side effects caused by Orlistat may limit its use. In this study the inhibitory activi...

      Obesity has become a worldwide health problem. Orlistat, an inhibitor of pancreatic lipase, is currently approved as an anti-obesity drug. However, gastrointestinal side effects caused by Orlistat may limit its use. In this study the inhibitory activities of dandelion (Taraxacum officinale) against pancreatic lipase in vitro and in vivo were measured to determine its possible use as a natural anti-obesity agent. The inhibitory activities of the 95% ethanol extract of T. officinale and Orlistat were measured using 4-methylumbelliferyl oleate (4-MU oleate) as a substrate at concentrations of 250, 125, 100, 25, 12.5 and 4 ㎍/㎖. To determine pancreatic lipase inhibitory activity in vivo, mice (n=16) were orally administered with corn oil emulsion (5 ㎖/㎏) alone or with the 95% ethanol extract of T. officinale (400 ㎎/㎏) following an overnight fast. Plasma triglyceride levels were measured at 0, 90, 180, and 240 min after treatment and incremental areas under the response curves (AUC) were calculated. The 95% ethanol extract of T. officinale and Orlistat, inhibited, porcine pancreatic lipase activity by 86.3% and 95.7% at a concentration of 250 ㎍/㎖, respectively. T. officinale extract showed dose-dependent inhibition with the IC50 of 78.2 μg/ml. A single oral dose of the extract significantly inhibited increases in plasma triglyceride levels at 90 and 180 min and reduced AUC of plasma triglyceride response curve (p<0.05). The results indicate that T. officinale exhibits inhibitory activities against pancreatic lipase in vitro and in vivo. Further studies to elucidate anti-obesity effects of chronic consumption of T. officinale and to identify the active components responsible for inhibitory activity against pancreatic lipase are necessary.

      더보기

      목차 (Table of Contents)

      • Abstract
      • Introduction
      • Materials and Methods
      • Results
      • Discussion
      • Abstract
      • Introduction
      • Materials and Methods
      • Results
      • Discussion
      • Literature cited
      더보기

      참고문헌 (Reference)

      1 조수열, "고콜레스테롤 흰쥐의 간조직 항산화효소계에 미치는 민들레잎 추출물의 영향" 한국식품영양과학회 32 (32): 458-463, 2003

      2 Thompson ABR, "in lipid metabolism, American Physiological Society New York, USA"

      3 Bisset NG, "Taraxaci radix cum herba. In: Herbal Drugs and Phytopharmaceuticals" Medpharm 486-489, 1994

      4 Han LK, "Saponins from Platycodi Radix ameliorate high fat diet-induced obesity in mice" 132 : 2241-2245, 2002

      5 Mokdad AH, "Prevalence of obesity, diabetes, and obesity-related health risk factors" 289 : 76-79, 2003

      6 Weigle DS, "Pharmacological therapy of obesity: past, present, and future" 88 : 2462-2469, 2003

      7 Jandacek RJ, "Pharmaceutical approaches to the treatment of obesity.Drug Discov Today" 15 : 874-880, 2004

      8 Birari RB, "Pancreatic lipase inhibitors from natural sources: unexplored potential" 12 : 879-889, 2007

      9 Ballinger A, "Orlistat: its current status as an anti-obesity drug" 440 : 109-117, 2002

      10 Aronne LJ, "Modern medical management of obesity: the role of pharmaceutical intervention" 98 : S23-26, 1998

      1 조수열, "고콜레스테롤 흰쥐의 간조직 항산화효소계에 미치는 민들레잎 추출물의 영향" 한국식품영양과학회 32 (32): 458-463, 2003

      2 Thompson ABR, "in lipid metabolism, American Physiological Society New York, USA"

      3 Bisset NG, "Taraxaci radix cum herba. In: Herbal Drugs and Phytopharmaceuticals" Medpharm 486-489, 1994

      4 Han LK, "Saponins from Platycodi Radix ameliorate high fat diet-induced obesity in mice" 132 : 2241-2245, 2002

      5 Mokdad AH, "Prevalence of obesity, diabetes, and obesity-related health risk factors" 289 : 76-79, 2003

      6 Weigle DS, "Pharmacological therapy of obesity: past, present, and future" 88 : 2462-2469, 2003

      7 Jandacek RJ, "Pharmaceutical approaches to the treatment of obesity.Drug Discov Today" 15 : 874-880, 2004

      8 Birari RB, "Pancreatic lipase inhibitors from natural sources: unexplored potential" 12 : 879-889, 2007

      9 Ballinger A, "Orlistat: its current status as an anti-obesity drug" 440 : 109-117, 2002

      10 Aronne LJ, "Modern medical management of obesity: the role of pharmaceutical intervention" 98 : S23-26, 1998

      11 Karamanos BG, "Maximal post-prandial triglyceride increases reflects post-prandial hypertriglyceridaemia and is associated with the insulin resistance syndrome" 18 : 32-39, 2001

      12 Hochuli E, "Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. II. Chemistry and structure elucidation" 40 : 1086-109, 1987

      13 Moreno DA, "Inhibitory effects of grape seed extract on lipases" 19 : 876-879, 2003

      14 Moreno DA, "Inhibition of lipid metabolic enzymes using Mangifera indica extracts" 4 : 21-26, 2006

      15 Arai I, "Improving effects of the extracts from Eugenia uniflora on hyperglycemia and hypertriglyceridemia in mice" 68 : 307-314, 1999

      16 Kurihara H, "Hypolipemic effect of Cyclocarya paliurus (Batal) Iljinskaja in lipid-loaded mice" 26 : 383-385, 2003

      17 Juhel C, "Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro" 11 : 45-51, 2000

      18 Williams CA, "Flavonoids, cinnamic acids and coumarins from the different tissues and medical preparations of Taraxacum officinale" 42 : 121-127, 1996

      19 Kurihara H, "Evaluation of the hypolipidemic property of Camellia sinensis Var.ptilophylla on postprandial hypertriglyceridemia J Agric Food Chem" 54 : 4977-4981, 2006

      20 Hye Young Kim, "Effects of Onion (Allium cepa) Skin Extract on Pancreatic Lipase andBody Weight-related Parameters" 한국식품과학회 16 (16): 434-438, 2007

      21 Cho SY, "Effect of dandelion leaf extracts on lipid metabolism in rats fed high cholesterol diet" 29 : 676-682, 2000

      22 Hu C, "Dandelion (Taraxacum officinale) flow extract suppresses both reactive oxygen species and nitric oxide and prevents lipid oxidation in vitro" 12 : 588-597, 2005

      23 Mascolo N, "Biological screening of Italian medical plants for anti-inflammatory activity" 1 : 28-31, 1987

      24 Yamamoto M, "Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet" 24 : 758-764, 2000

      25 Han LK, "Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor" 25 : 1459-1464, 2001

      26 Weibel EK, "An inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity" 40 : 1081-1085, 1987

      27 Cho SY, "Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract" 317 : 109-117, 2002

      28 Olshansky SJ, "A potential decline in life expectancy in the United States in the 21st century" 352 : 1135-1137, 2005

      29 Shin JE, "3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase" 26 : 854-857, 2003

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-25 학술지등록 한글명 : Nutrition Research and Practice
      외국어명 : Nutrition Research and Practice
      KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.83 0.43 1.45
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.21 1.05 0.727 0.15
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼